THE GENERAL ASSEMBLY OF PENNSYLVANIA

HOUSE BILL

INTRODUCED BY MANN, BAKER, BARRAR, BOBACK, BOYD, BRENNAN, CALTAGIRONE, CARROLL, D. COSTA, DeLUCA, DiGIROLAMO, FABRIZIO, FLECK, GEIST, GERGELY, GINGRICH, GROVE, HARHAI, HARRIS, HESS, HICKERNELL, JOSEPHS, KILLION, KNOWLES, KORTZ, KOTIK, KULA, LONGIETTI, MARSICO, MATZIE, METZGAR, MILLARD, MILLER, MOUL, MURPHY, O'NEILL, PASHINSKI, PEIFER, PYLE, READSHAW, SCAVELLO, K. SMITH, SWANGER, TALLMAN, TOEPEL, VULAKOVICH, WATSON, YOUNGBLOOD, HENNESSEY, QUINN, DENLINGER, MURT, CLYMER AND STERN, JANUARY 21, 2011

AS REPORTED FROM COMMITTEE ON JUDICIARY, HOUSE OF REPRESENTATIVES, AS AMENDED, FEBRUARY 15, 2011   

AN ACT

Amending the act of April 14, 1972 (P.L.233, No.64), entitled

"An act relating to the manufacture, sale and possession of

controlled substances, other drugs, devices and cosmetics;

conferring powers on the courts and the secretary and

Department of Health, and a newly created Pennsylvania Drug,

Device and Cosmetic Board; establishing schedules of

controlled substances; providing penalties; requiring

registration of persons engaged in the drug trade and for the

revocation or suspension of certain licenses and

registrations; and repealing an act," further providing for

schedules of controlled substances.

The General Assembly of the Commonwealth of Pennsylvania

hereby enacts as follows:

Section 1.  Section 4(1)(iii) of the act of April 14, 1972

<--

(P.L.233, No.64), known as The Controlled Substance, Drug,

Device and Cosmetic Act, amended November 24, 1999 (P.L.894,

No.55), is amended and clause (1) is amended by adding a

subclause to read:

Section 1.  Section 4(1) of the act of April 14, 1972

<--

(P.L.233, No.64), known as The Controlled Substance, Drug,

Device and Cosmetic Act, is amended by adding a subclause to

read:

Section 4.  Schedules of Controlled Substances.--The

following schedules include the controlled substances listed or

to be listed by whatever official name, common or usual name,

chemical name, or trade name designated.

(1)  Schedule I--In determining that a substance comes within

this schedule, the secretary shall find: a high potential for

abuse, no currently accepted medical use in the United States,

and a lack of accepted safety for use under medical supervision.

The following controlled substances are included in this

schedule:

* * *

<--

(iii)  Any material, compound, mixture, or preparation which

contains any quantity of the following hallucinogenic

substances, their salts, isomers, and salts of isomers, unless

specifically excepted, whenever the existence of such salts,

isomers, and salts of isomers is possible within the specific

chemical designation:

 1.  3,4-methylenedioxy amphetamine.

 2.  5-methoxy-3,4-methylenedioxy amphetamine.

 3.  3,4,5-trimethoxy amphetamine.

 4.  Bufotenine.

 5.  Diethyltryptamine.

 6.  Dimethyltryptamine.

 7.  4-methyl-2,5-dimethoxyamphetamine.

 8.  Ibogaine.

 9.  Lysergic acid diethylamide.

10.  Mescaline.

11.  Peyote.

12.  N-ethyl-3-piperidyl benzilate.

13.  N-methyl-3-piperidyl benzilate.

14.  Psilocybin.

15.  Psilocyn.

16.  Tetrahydrocannabinols.

17.  Divinorin A.

18.  Salvia Divinorum.

19.  Salvinorin A.

* * *

(vii)  Synthetic cannabinoids as follows:

1.  CP 47,497 and homologues, 2-[(1R,3S)-3-

hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol).

2.  HU-210, [(6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-

methyloctan-2-yl)-6a,7,10, 10a-tetrahydrobenzo[c] chromen-1-

ol)].

3.  HU-211, (dexanabinol, (6aS,10aS)-9-(hydroxymethyl)-6,6-

dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-

tetrahydrobenzo[c]chromen-1-ol).

4.  JWH-018, 1-Pentyl-3-(1-naphthoyl)indole.

5.  JWH-019, 1-Hexyl-3-(1-naphthoyl)indole.

6.  JWH-073, 1-Butyl-3-(1-naphthoyl)indole.

7.  JWH-200, (1-(2-morpholin-4-ylethyl)indol-3-yl)-

naphthalen-1-ylmethanone.

8.  JWH-250, 1-pentyl-3-(2-methoxyphenylacetyl)indole.

* * *

Section 2.  This act shall take effect in 60 days.